Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Zoetis Inc.

NYSE

Market Cap.

79.42B

Avg. Volume

3.69M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Zoetis Inc.!

Still processing it, give me a bit more time...

Zoetis Inc. News

Zoetis Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
zoetis.com

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Zoetis Inc. Earnings & Revenue

Zoetis Inc. Financials

Table Compare

Compare ZTS metrics with:

   

Earnings & Growth

ZTS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZTS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZTS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZTS

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Zoetis Inc. Income

Zoetis Inc. Balance Sheet

Zoetis Inc. Cash Flow

Zoetis Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Zoetis Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6139999999999999

Payment DateDividendFrequency
2024-06-040.432Quarterly
2024-03-010.432Quarterly
2023-12-010.375Quarterly
2023-09-010.375Quarterly
2023-06-010.375Quarterly

Historical Market Cap

Shares Outstanding

Zoetis Inc. Executives

NameRole
Ms. Kristin C. PeckChief Executive Officer & Director
Mr. Wetteny N. JosephExecutive Vice President & Chief Financial Officer
Ms. Wafaa MamilliEVice President, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health
Ms. Heidi C. ChenEmployee Advisor
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development
NameRoleGenderDate of BirthPay
Ms. Kristin C. PeckChief Executive Officer & DirectorFemale19713.54M
Mr. Wetteny N. JosephExecutive Vice President & Chief Financial OfficerMale19721.6M
Ms. Wafaa MamilliEVice President, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal HealthFemale19671.36M
Ms. Heidi C. ChenEmployee AdvisorFemale19671.24M
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development19691.18M

Zoetis Inc. Insider Trades

Date18 Apr
NameLagano Roxanne
RoleExecutive Vice President
TransactionDisposed
TypeS-Sale
Shares923
Date5 Apr
NameLagano Roxanne
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares280.7765
Date5 Apr
NameMamilli Wafaa
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares411.1799
Date5 Apr
NameJoseph Wetteny
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares580.9293
Date5 Apr
NameDriscoll Rimma
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares16.2331
DateNameRoleTransactionTypeShares
18 AprLagano RoxanneExecutive Vice PresidentDisposedS-Sale923
5 AprLagano RoxanneExecutive Vice PresidentAcquiredA-Award280.7765
5 AprMamilli WafaaExecutive Vice PresidentAcquiredA-Award411.1799
5 AprJoseph WettenyChief Financial OfficerAcquiredA-Award580.9293
5 AprDriscoll RimmaExecutive Vice PresidentAcquiredA-Award16.2331

Discover More

Streamlined Academy

Zoetis Inc.

NYSE

Market Cap.

79.42B

Avg. Volume

3.69M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Zoetis Inc. News

Zoetis Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Zoetis Inc. Earnings & Revenue

Zoetis Inc. Income

Zoetis Inc. Balance Sheet

Zoetis Inc. Cash Flow

Zoetis Inc. Financials Over Time

Zoetis Inc. Executives

NameRole
Ms. Kristin C. PeckChief Executive Officer & Director
Mr. Wetteny N. JosephExecutive Vice President & Chief Financial Officer
Ms. Wafaa MamilliEVice President, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health
Ms. Heidi C. ChenEmployee Advisor
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development
NameRoleGenderDate of BirthPay
Ms. Kristin C. PeckChief Executive Officer & DirectorFemale19713.54M
Mr. Wetteny N. JosephExecutive Vice President & Chief Financial OfficerMale19721.6M
Ms. Wafaa MamilliEVice President, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal HealthFemale19671.36M
Ms. Heidi C. ChenEmployee AdvisorFemale19671.24M
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development19691.18M

Zoetis Inc. Insider Trades

Date18 Apr
NameLagano Roxanne
RoleExecutive Vice President
TransactionDisposed
TypeS-Sale
Shares923
Date5 Apr
NameLagano Roxanne
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares280.7765
Date5 Apr
NameMamilli Wafaa
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares411.1799
Date5 Apr
NameJoseph Wetteny
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares580.9293
Date5 Apr
NameDriscoll Rimma
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares16.2331
DateNameRoleTransactionTypeShares
18 AprLagano RoxanneExecutive Vice PresidentDisposedS-Sale923
5 AprLagano RoxanneExecutive Vice PresidentAcquiredA-Award280.7765
5 AprMamilli WafaaExecutive Vice PresidentAcquiredA-Award411.1799
5 AprJoseph WettenyChief Financial OfficerAcquiredA-Award580.9293
5 AprDriscoll RimmaExecutive Vice PresidentAcquiredA-Award16.2331

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
zoetis.com

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Zoetis Inc.!

Still processing it, give me a bit more time...

Zoetis Inc. Financials

Table Compare

Compare ZTS metrics with:

   

Earnings & Growth

ZTS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZTS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZTS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZTS

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Zoetis Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6139999999999999

Payment DateDividendFrequency
2024-06-040.432Quarterly
2024-03-010.432Quarterly
2023-12-010.375Quarterly
2023-09-010.375Quarterly
2023-06-010.375Quarterly

Zoetis Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More